Table 2.
Dysgeusia experienced in each patient
| Age | ≤59 | 60–69 | 70–79 | ≥80 | Total |
|---|---|---|---|---|---|
| Therapy |
|
|
|
|
|
| 5-FU total |
4/6 (66.7) |
2/10 (20.0) |
4/8 (50.0) |
3/3 (100) |
13/27 (48.1) |
| Oral analogs |
2/3 (66.7) |
2/7 (28.6) |
4/6 (66.7) |
2/2 (100) |
10/18 (55.6) |
| 5-FU |
2/3 (66.7) |
0/3 (0) |
0/2 (0) |
1/1 (100) |
3/9 (33.3) |
| Pt |
2/3 (66.7) |
2/9 (22.2) |
0/4 (0) |
- |
16/38 (42.1) |
| Tx |
1/3 (33.3) |
0/1 (0) |
1/1 (100) |
- |
5/38 (13.2) |
| Others |
0/3 (0) |
1/6 (16.7) |
0/1 (0) |
- |
1/10 (10.0) |
| Off | 0/2 (0) | 1/3 (33.3) | 1/3 (33.3) | - | 2/8 (25.0) |
The number of patients who experienced dysgeusia during therapy is indicated per total number undergoing chemotherapy. Numbers in parentheses indicate the percentage. Type of chemotherapy is indicated in the first column. Off off-chemotherapy.